QURE Return on Tangible Equity | uniQure N.V.

uniQure N.V. (QURE) Return on Tangible Equity

2026-03-31: Return Tang Equity -182.13%.
2025-12-31: Return Tang Equity -121.55%.
2025-09-30: Return Tang Equity -181.90%.
2025-06-30: Return Tang Equity 189.61%.

Complete source-backed return tang equity history.

Available history: 2015-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-03-31	-182.13%
2025-12-31	-121.55%
2025-09-30	-181.90%
2025-06-30	189.61%
2025-03-31	352.88%
2024-12-31	537.47%
2024-09-30	533.74%
2024-06-30	-1775.89%
2024-03-31	-338.32%
2023-12-31	-105.77%
2023-03-31	-33.29%
2022-12-31	-18.70%
2022-03-31	-17.61%
2021-12-31	-12.28%
2021-03-31	-49.58%
2020-12-31	-40.79%
2020-03-31	-41.43%
2019-12-31	-34.65%
2019-03-31	-63.65%
2018-12-31	-50.85%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-121.55%
2024-12-31	537.47%
2023-12-31	-171.44%
2022-12-31	-32.37%
2021-12-31	65.21%
2020-12-31	-52.09%
2019-12-31	-39.16%
2018-12-31	-47.90%
2017-12-31	-100.00%
2016-12-31	-133.79%
2015-12-31	-68.04%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)	United States	$2.517B	-24.63
Immunome Inc. (IMNM)	United States	$2.538B	-9.45
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
Zai Lab Ltd (ZLAB)		$2.241B	-113.34